drugs LOW RISK Updated 2026-07-29

Ascend Laboratories, LLC recalls Dabigatran etexilate Capsules, 110 mg, 60-count carton (6x10

See all recalls from Ascend Laboratories, LLC →

Recalled Product

Dabigatran etexilate Capsules, 110 mg, 60-count carton (6x10), Rx Only, Manufactured by: Alkem Laboratories, Mumbai, INDIA, Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-7254-68.

Share this recall: Facebook X / Twitter WhatsApp Email

Hazard / Issue

Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12 Month Long-Term Stability.

Issued by

FDA

Distribution: Nationwide (United States)
Lot/Code Info: Lot: 25141707, Exp 4/30/2027.

✅ What Should You Do?

  1. 1Stop taking this medication and contact your doctor or pharmacist immediately.
  2. 2Do NOT flush medications down the drain — use an FDA-approved drug take-back program.
  3. 3Check the lot number on your bottle or packaging against the recalled lots listed above.
  4. 4Report adverse events to FDA MedWatch or call 1-800-FDA-1088.
View official government recall